A First Human Dose Study Investigating Safety and Concentration of Study Medicine in the Blood Following Once Daily Oral Dosing of NNC0560-0004 in Healthy Adults.

Conditions: Healthy Volunteers - Liver Diseases Interventions: Drug: NNC0560-0004; Drug: Placebo (NNC0560-0004) Sponsors: Novo Nordisk A/S Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials